Danielle Gerhard, PhD | Mar 22, 2024 | 10+ min read
With the help of directed evolution, scientists inch closer to developing viral vectors that can cross the human blood-brain barrier to deliver gene therapy.
Flavivirus infections alter the skin microbiome of mice to increase the production of a sweet-smelling compound that attracts the viruses’ insect vectors, a study finds.
Different variants of the virus behind the COVID-19 pandemic are swapping chunks of genetic material, but it’s not yet clear what implications that may have for public health.
Face it, you're an agent! Scientists should really consider themselves professional promoters-promoters not too different from the type portrayed in a not-to-be-mentioned recent movie (it made enough money). Our clients are not jocks looking for some franchise to pick up a multi-year contract; our clients are genes that have biologically-athletic capabilities. Consider that genes are not just average run-of-the-mill sequences playing weekend pick-up games whenever they get enough friends togeth
This month marks the 100-year anniversary of BCG, still the only approved vaccine against the lethal pathogen. But there are new vaccines for this wily foe on the horizon.